Decreased expression of GLT-1 in the R6/2 model of Huntington's disease does not worsen disease progression

European Journal of Neuroscience

Volumn 38, Issue 3, 2013, Pages 2477-2490

  Petr, Geraldine T ^a,b   Schultheis, Laurel A ^a   Hussey, Kayla C ^a   Sun, Yan ^a,b   Dubinsky, Janet M ^c   Aoki, Chiye ^d   Rosenberg, Paul A ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

EM ICC; Glutamate transporter; Na+ dependent glutamate uptake; R6 2; Synaptosomes

Indexed keywords

GLUCOSE TRANSPORTER 1; GLUTAMATE RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN CORTEX; CAG REPEAT; CELL DENSITY; CELL ISOLATION; CLIMBING; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; DNA EXTRACTION; EXCITOTOXICITY; FEMALE; GENE MUTATION; GENOTYPE; HUNTINGTON CHOREA; IMMUNOREACTIVITY; MOUSE; NEUROTRANSMISSION; NONHUMAN; NULL ALLELE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; ROTAROD TEST; SYNAPTOSOME; TRANSGENE; WEIGHT REDUCTION; WESTERN BLOTTING;

EID: 84881317019     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12202     Document Type: Article

References (65)

1. Arzberger, T., Krampfl, K., Leimgruber, S. & Weindl, A. (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease-an in situ hybridization study. J. Neuropath. Exp. Neur., 56, 440-454.
2. Auger, C. & Attwell, D. (2000) Fast removal of synaptic glutamate by postsynaptic transporters. Neuron, 28, 547-558.
3. Balcar, V.J. & Li, Y. (1992) Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system. Life Sci., 51, 1467-1478.
4. Beal, M.F., Ferrante, R.J., Swartz, K.J. & Kowall, N.W. (1991) Chronic quinolinic acid lesions in rats closely resemble Huntington's disease. J. Neurosci., 11, 1649-1659.
5. Behrens, P.F., Franz, P., Woodman, B., Lindenberg, K.S. & Landwehrmeyer, G.B. (2002) Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain, 125, 1908-1922.
6. Bramham, C.R., Torp, R., Zhang, N., Storm-Mathisen, J. & Ottersen, O.P. (1990) Distribution of glutamate-like immunoreactivity in excitatory hippocampal pathways: a semiquantitative electron microscopic study in rats. Neuroscience, 39, 405-417.
7. Brustovetsky, T., Purl, K., Young, A., Shimizu, K. & Dubinsky, J.M. (2004) Dearth of glutamate transporters contributes to striatal excitotoxicity. Exp. Neurol., 189, 222-230.
8. van der Burg, J.M., Bacos, K., Wood, N.I., Lindqvist, A., Wierup, N., Woodman, B., Wamsteeker, J.I., Smith, R., Deierborg, T., Kuhar, M.J., Bates, G.P., Mulder, H., Erlanson-Albertsson, C., Morton, A.J., Brundin, P., Petersen, A. & Bjorkqvist, M. (2008) Increased metabolism in the R6/2 mouse model of Huntington's disease. Neurobiol. Dis., 29, 41-51.
9. Carter, R.J., Lione, L.A., Humby, T., Mangiarini, L., Mahal, A., Bates, G.P., Dunnett, S.B. & Morton, A.J. (1999) Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci., 19, 3248-3257.
10. Chan, J., Aoki, C. & Pickel, V.M. (1990) Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J. Neurosci. Meth., 33, 113-127.
11. Chen, W., Aoki, C., Mahadomrongkul, V., Gruber, C.E., Wang, G.J., Blitzblau, R., Irwin, N. & Rosenberg, P.A. (2002) Expression of a variant form of the glutamate transporter GLT1 in neuronal cultures and in neurons and astrocytes in the rat brain. J. Neurosci., 22, 2142-2152.
12. Chen, W., Mahadomrongkul, V., Berger, U.V., Bassan, M., DeSilva, T., Tanaka, K., Irwin, N., Aoki, C. & Rosenberg, P.A. (2004) The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons. J. Neurosci., 24, 1136-1148.
13. Cross, A.J., Slater, P. & Reynolds, G.P. (1986) Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington's disease. Neurosci. Lett., 67, 198-202.
14. Danbolt, N.C. (2001) Glutamate uptake. Prog. Neurobiol., 65, 1-105.
15. Danbolt, N.C., Storm-Mathisen, J. & Kanner, B.I. (1992) An [Na+ + K+]coupled L-glutamate transporter purified from rat brain is located in glial cell processes. Neuroscience, 51, 295-310.
16. Danbolt, N.C., Furness, D.N., Dehnes, Y., Qureshi, A., Rossi, D., Hamann, M., Grutle, N.J., Gunderen, V., Holmseth, S., Lehre, K.P., Ullensvang, K., Wojewodzic, M. & Attwell, D. (2006) A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes. Program No. 629.8. 2006 Neuroscience Meeting Planner. Atlanta, GA: Society for Neuroscience, 2006. Online.
17. Divac, I., Fonnum, F. & Storm-Mathisen, J. (1977) High affinity uptake of glutamate in terminals of corticostriatal axons. Nature, 266, 377-378.
18. Erecinska, M. & Silver, I.A. (1990) Metabolism and role of glutamate in mammalian brain. Prog. Neurobiol., 35, 245-296.
19. Estrada-Sanchez, A.M., Montiel, T., Segovia, J. & Massieu, L. (2009) Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. Neurobiol. Dis., 34, 78-86.
20. Fonnum, F., Storm-Mathisen, J. & Divac, I. (1981) Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain. Neuroscience, 6, 863-873.
21. Furness, D.N., Dehnes, Y., Akhtar, A.Q., Rossi, D.J., Hamann, M., Grutle, N.J., Gundersen, V., Holmseth, S., Lehre, K.P., Ullensvang, K., Wojewodzic, M., Zhou, Y., Attwell, D. & Danbolt, N.C. (2008) A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2). Neuroscience, 157, 80-94.
22. Gundersen, V., Ottersen, O.P. & Storm-Mathisen, J. (1996) Selective excitatory amino acid uptake in glutamatergic nerve terminals and in glia in the rat striatum: quantitative electron microscopic immunocytochemistry of exogenous (D)-aspartate and endogenous glutamate and GABA. Eur. J. Neurosci., 8, 758-765.
23. Hassel, B., Tessler, S., Faull, R.L. & Emson, P.C. (2008) Glutamate uptake is reduced in prefrontal cortex in Huntington's disease. Neurochem. Res., 33, 232-237.
24. Haugeto, O., Ullensvang, K., Levy, L.M., Chaudhry, F.A., Honore, T., Nielsen, M., Lehre, K.P. & Danbolt, N.C. (1996) Brain glutamate transporter proteins form homomultimers. J. Biol. Chem., 271, 27715-27722.
25. Herman, M.A. & Jahr, C.E. (2007) Extracellular glutamate concentration in hippocampal slice. J. Neurosci., 27, 9736-9741.
26. Hickey, M.A., Gallant, K., Gross, G.G., Levine, M.S. & Chesselet, M.F. (2005) Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiol. Dis., 20, 1-11.
27. Hsu, S.M., Raine, L. & Fanger, H. (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29, 577-580.
28. Huang, K., Kang, M.H., Askew, C., Kang, R., Sanders, S.S., Wan, J., Davis, N.G. & Hayden, M.R. (2010) Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease. Neurobiol. Dis., 40, 207-215.
29. Kalandadze, A., Wu, Y. & Robinson, M.B. (2002) Protein kinase C activation decreases cell surface expression of the GLT-1 subtype of glutamate transporter. Requirement of a carboxyl-terminal domain and partial dependence on serine 486. J. Biol. Chem., 277, 45741-45750.
30. Kiryk, A., Aida, T., Tanaka, K., Banerjee, P., Wilczynski, G.M., Meyza, K., Knapska, E., Filipkowski, R.K., Kaczmarek, L. & Danysz, W. (2008) Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction. Neurotox. Res., 13, 19-30.
31. Lee, A. & Pow, D.V. (2010) Astrocytes: glutamate transport and alternate splicing of transporters. Int. J. Biochem. Cell B., 42, 1901-1906.
32. Lee, S.G., SU, Z.Z., Emdad, L., Gupta, P., Sarkar, D., Borjabad, A., Volsky, D.J. & Fisher, P.B. (2008) Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J. Biol. Chem., 283, 13116-13123.
33. Lehre, K.P., Levy, L.M., Ottersen, O.P., Storm-Mathisen, J. & Danbolt, N.C. (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci., 15, 1835-1853.
34. Lewerenz, J., Albrecht, P., Tien, M.L., Henke, N., Karumbayaram, S., Kornblum, H.I., Wiedau-Pazos, M., Schubert, D., Maher, P. & Methner, A. (2009) Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro. J. Neurochem., 111, 332-343.
35. Li, X., Valencia, A., Sapp, E., Masso, N., Alexander, J., Reeves, P., Kegel, K.B., Aronin, N. & Difiglia, M. (2010) Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease. J. Neurosci., 30, 4552-4561.
36. Lievens, J.C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L. & Bates, G.P. (2001) Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol. Dis., 8, 807-821.
37. Lipton, S.A. & Rosenberg, P.A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med., 330, 613-622.
38. Matsubara, A., Laake, J.H., Davanger, S., Usami, S. & Ottersen, O.P. (1996) Organization of AMPA receptor subunits at a glutamate synapse: a quantitative immunogold analysis of hair cell synapses in the rat organ of Corti. J. Neurosci., 16, 4457-4467.
39. Matsugami, T.R., Tanemura, K., Mieda, M., Nakatomi, R., Yamada, K., Kondo, T., Ogawa, M., Obata, K., Watanabe, M., Hashikawa, T. & Tanaka, K. (2006) From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development. Proc. Natl. Acad. Sci. USA, 103, 12161-12166.
40. Melzer, N., Meuth, S.G., Torres-Salazar, D., Bittner, S., Zozulya, A.L., Weidenfeller, C., Kotsiari, A., Stangel, M., Fahlke, C. & Wiendl, H. (2008) A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis. PLoS ONE, 3, e3149.
41. Miller, B.R., Dorner, J.L., Shou, M., Sari, Y., Barton, S.J., Sengelaub, D.R., Kennedy, R.T. & Rebec, G.V. (2008) Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse. Neuroscience, 153, 329-337.
42. Mitani, A. & Tanaka, K. (2003) Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci., 23, 7176-7182.
43. Oeckinghaus, A. & Ghosh, S. (2009) The NF-kappaB family of transcription factors and its regulation. Cold. Spring. Harb. Perspect. Biol., 1, a000034.
44. Olsson, I.A. & Dahlborn, K. (2002) Improving housing conditions for laboratory mice: a review of "environmental enrichment". Lab Animal, 36, 243-270.
45. Petr, G.T., Frederick, N.M., Corfas, G., Aoki, C.J. & Rosenberg, P.A. (2011) The contribution of the glutamate transporter GLT-1 expressed in neurons to synaptosomal uptake of glutamate. Program No. 342.10. 2011 Neuroscience Meeting Planner. Washington, DC: Society for Neuroscience, 2011. Online.
46. Phend, K.D., Rustioni, A. & Weinberg, R.J. (1995) An osmium-free method of epon embedment that preserves both ultrastructure and antigenicity for post-embedding immunocytochemistry. J. Histochem. Cytochem., 43, 283-292.
47. Rakhade, S.N. & Loeb, J.A. (2008) Focal reduction of neuronal glutamate transporters in human neocortical epilepsy. Epilepsia, 49, 226-236.
48. Robinson, M.B., Djali, S. & Buchhalter, J.R. (1993) Inhibition of glutamate uptake with L-trans-pyrrolidine-2, 4-dicarboxylate potentiates glutamate toxicity in primary hippocampal cultures. J. Neurochem., 61, 2099-2103.
49. Rosenberg, P.A. & Aizenman, E. (1989) Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci. Lett., 103, 162-168.
50. Rosenberg, P.A., Amin, S. & Leitner, M. (1992) Glutamate uptake disguises neurotoxic potency of glutamate agonists in cerebral cortex in dissociated cell culture. J. Neurosci., 12, 56-61.
51. Rothstein, J.D., Martin, L., Levey, A.I., Dykes-Hoberg, M., Jin, L., Wu, D., Nash, N. & Kuncl, R.W. (1994) Localization of neuronal and glial glutamate transporters. Neuron, 13, 713-725.
52. Rothstein, J.D., Dykes-Hoberg, M., Pardo, C.A., Bristol, L.A., Jin, L., Kuncl, R.W., Kanai, Y., Hediger, M.A., Wang, Y., Schielke, J.P. & Welty, D.F. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron, 16, 675-686.
53. Sari, Y., Prieto, A.L., Barton, S.J., Miller, B.R. & Rebec, G.V. (2010) Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease. J. Biomed. Sci., 17, 62.
54. Sasaki, H., Sato, H., Kuriyama-Matsumura, K., Sato, K., Maebara, K., Wang, H., Tamba, M., Itoh, K., Yamamoto, M. & Bannai, S. (2002) Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J. Biol. Chem., 277, 44765-44771.
55. Senatorov, V.V., Charles, V., Reddy, P.H., Tagle, D.A. & Chuang, D.M. (2003) Overexpression and nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase in a transgenic mouse model of Huntington's disease. Mol. Cell. Neurosci., 22, 285-297.
56. Sheldon, A.L. & Robinson, M.B. (2007) The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int., 51, 333-355.
57. Shin, J.Y., Fang, Z.H., Yu, Z.X., Wang, C.E., Li, S.H. & Li, X.J. (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J. Cell Biol., 171, 1001-1012.
58. Stack, E.C., Kubilus, J.K., Smith, K., Cormier, K., Del Signore, S.J., Guelin, E., Ryu, H., Hersch, S.M. & Ferrante, R.J. (2005) Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice. J. Comp. Neurol., 490, 354-370.
59. Sun, Y., Petr, G.T., Frederick, N.M., Aoki, C.J., Rotenberg, A., Dhamne, S.C., Hameed, M.Q., Goodrich, G.S., Armsen, W. & Rosenberg, P.A. (2012) Cell-type specific expression and function of the glutamate transporter GLT-1 at excitatory synapses probed with conditional deletion. Program No. 332.16. 2012 Neuroscience Meeting Planner. New Orleans, LA: Society for Neuroscience, 2012. Online.
60. Takasaki, C., Okada, R., Mitani, A., Fukaya, M., Yamasaki, M., Fujihara, Y., Shirakawa, T., Tanaka, K. & Watanabe, M. (2008) Glutamate transporters regulate lesion-induced plasticity in the developing somatosensory cortex. J. Neurosci., 28, 4995-5006.
61. Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., Okuyama, S., Kawashima, N., Hori, S., Takimoto, M. & Wada, K. (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science, 276, 1699-1702.
62. The Huntington's Disease Collaborative Research Group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72, 971-983.
63. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D. & Richardson, E.P. Jr. (1985) Neuropathological classification of Huntington's disease. J. Neuropath. Exp. Neur., 44, 559-577.
64. Wadiche, J.I. & Kavanaugh, M.P. (1998) Macroscopic and microscopic properties of a cloned glutamate transporter/chloride channel. J. Neurosci., 18, 7650-7661.
65. Yanai, A., Huang, K., Kang, R., Singaraja, R.R., Arstikaitis, P., Gan, L., Orban, P.C., Mullard, A., Cowan, C.M., Raymond, L.A., Drisdel, R.C., Green, W.N., Ravikumar, B., Rubinsztein, D.C., El-Husseini, A. & Hayden, M.R. (2006) Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function. Nat. Neurosci., 9, 824-831.